earnings
confidence high
sentiment neutral
materiality 0.75
Bristol Myers Q4 rev $12.5B (+1%), non-GAAP EPS $1.26; dividend raised to $0.63/share; FY2026 guidance rev $46-47.5B
BRISTOL MYERS SQUIBB CO
2025-FY EPS reported
$3.46
revenue$48,194,000,000
- Q4 revenue $12.5B (+1% YoY); Growth Portfolio rev $7.4B (+16%). Full-year rev $48.2B.
- GAAP EPS Q4 $0.53, FY $3.46; Non-GAAP EPS Q4 $1.26, FY $6.15.
- 2026 guidance: revenue ~$46-47.5B, non-GAAP EPS $6.05-6.35.
- Quarterly dividend raised to $0.63/share, 17th consecutive annual increase.
- Acquired IPRD charges and licensing income net impact of $(0.60) on Q4 EPS.